Skip to content
Tenfell
Awarded contract
Published 13 May 2021

NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche

NHS England · London

Key facts

Awarded
11 Feb 2021
Contract starts
01 Mar 2021
Contract ends
28 Feb 2023
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 28 suppliers

SupplierValue
Accord-UK Ltd—
Allergan Limited—
Amgen Ltd—
AstraZeneca—
Biogen—
Bristol Myers Squibb—
Chugai—
Eli Lilly & Company Ltd—
Ferring Pharmaceuticals Limited—
Ipsen—
Janssen-Cilag Ltd—
Merck Serono Limited—
Merck Sharpe & Dohme (UK) Limited—
Merz—
Napp Pharmaceuticals—
Novartis Pharmaceuticals UK Ltd—
Novo Nordisk—
Organon Pharmaceuticals UK Ltd—
Pfizer Ltd—
Pharmacosmos UK Ltd—
Roche Products Ltd—
Sandoz Ltd—
Teva UK Ltd—
Thornton & Ross Ltd—
UCB Pharma Ltd—
Vifor Pharma UK Limited—
Celltrion Healthcare United Kingdom Limited—
Gedeon Richter UK Ltd—

Description

NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.